601 results on '"White, Eric S"'
Search Results
102. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
103. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis
104. Routine Chest Radiography for the Evaluation of Pneumothorax Following Bronchoscopy
105. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
106. Hypersensitivity Pneumonitis
107. Extracellular matrix in lung development, homeostasis and disease
108. αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis
109. Sarcoidosis Involving Multiple Systems: Diagnostic and The rapeutic Challenges
110. Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through α2β1 Integrin.
111. Investigating effects of nintedanib on biomarkers of ECM turnover in patients with IPF: the INMARK study
112. Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt
113. Wilms’ tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease
114. Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
115. Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
116. Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis
117. The ED-A domain enhances the capacity of fibronectin to store latent TGF-β binding protein-1 in the fibroblast matrix
118. In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells
119. Correction: Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis (doi: 10.1242/dmm.030114)
120. Bioengineered lungs generated from human i PSC s‐derived epithelial cells on native extracellular matrix
121. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
122. Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring
123. Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
124. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
125. The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
126. Hsp90 regulation of fibroblast activation in pulmonary fibrosis
127. In vitroinduction andin vivoengraftment of lung bud tip progenitor cells derived from human pluripotent stem cells
128. MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
129. Mechanisms of pulmonary fibrosis
130. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias
131. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
132. Association Between Lung Microbiome and Disease Progression in IPF: A Prospective Cohort Study
133. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids
134. Author response: A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids
135. Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF
136. Commentary: A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia
137. IL-36γ is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components
138. Animal and cellular models of human disease
139. Recommendations for minimum information for publication of experimental pathology data: MINPEPA guidelines
140. Plakoglobin expression in fibroblasts and its role in idiopathic pulmonary fibrosis
141. Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction
142. Fibrocytes Regulate Wilms Tumor 1–Positive Cell Accumulation in Severe Fibrotic Lung Disease
143. Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids
144. Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.
145. Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebocontrolled INMARK®trial.
146. Bioengineered lungs generated from human iPSCs‐derived epithelial cells on native extracellular matrix.
147. In vitro generation of human pluripotent stem cell derived lung organoids
148. Author response: In vitro generation of human pluripotent stem cell derived lung organoids
149. Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs
150. Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.